Successful multi-target therapy using corticosteroid, tacrolimus, cyclophosphamide, and rituximab for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis

被引：13
|
作者：
Watanabe, Ryu [1 ]
Ishii, Tomonori [1 ]
Araki, Kyoko [1 ]
Ishizuka, Mariko [1 ]
Kamogawa, Yukiko [1 ]
Fujita, Yoko [1 ]
Shirota, Yuko [1 ]
Fujii, Hiroshi [1 ]
Harigae, Hideo [1 ]
机构：
[1] Tohoku Univ, Grad Sch Med, Dept Hematol & Rheumatol, Sendai, Miyagi 9808574, Japan
来源：
MODERN RHEUMATOLOGY | 2016年 / 26卷 / 03期
关键词：
Clinically amyopathic dermatomyositis; Interstitial lung disease; Multi-target therapy; Rituximab; ANTIBODY;
D O I：
10.3109/14397595.2015.1012797
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：465 / 466
页数：2
相关论文
共 50 条
  • [31] Rapidly progressive interstitial lung disease associated with dermatomyositis responding to intravenous cyclophosphamide pulse therapy
    Shinohara, T
    Hidaka, T
    Matsuki, Y
    Ishizuka, T
    Takamizawa, M
    Kawakami, M
    Kikuma, H
    Suzuki, K
    Nakamura, H
    INTERNAL MEDICINE, 1997, 36 (07) : 519 - 523
  • [32] Successful Treatment of Rapidly Progressive Interstitial Lung Disease in Juvenile Dermatomyositis
    Ciaglia, Kristina
    Ghawji, Maria
    Caraballo, Michelle
    Sloan, Elizabeth
    PEDIATRICS, 2024, 153 (03)
  • [33] Correlation between disease activity and serum ferritin in clinically amyopathic dermatomyositis with rapidly-progressive interstitial lung disease: A case report
    Yamada K.
    Asai K.
    Okamoto A.
    Watanabe T.
    Kanazawa H.
    Ohata M.
    Ohsawa M.
    Hirata K.
    BMC Research Notes, 11 (1)
  • [34] Early Diagnosis and Treatment of Rapidly Progressive Interstitial Lung Disease Caused by Clinical Amyopathic Dermatomyositis
    Kim, A. H.
    Duarte, F. E.
    Rhee, J.
    Gumpeni, R.
    Shang, Y.
    Zuckerman, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [35] Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study
    Shuang Ye
    Xiao-xiang Chen
    Xiao-ye Lu
    Mei-fang Wu
    Yun Deng
    Wen-qun Huang
    Qiang Guo
    Cheng-de Yang
    Yue-ying Gu
    Chun-de Bao
    Shun-le Chen
    Clinical Rheumatology, 2007, 26 : 1647 - 1654
  • [36] Successful Treatment Of Rapidly Progressive Interstitial Lung Disease Due To Melanoma Differentiation Associated Gene 5 (mda5) Antibody Associated Clinically Amyopathic Dermatomyositis With Cyclophosphamide And Intravenous Immunoglobulin
    Reagle, Z.
    Andrews, S.
    DeJesus, E.
    Yuvienco, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [37] Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study
    Ye, Shuang
    Chen, Xiao-xiang
    Lu, Xiao-ye
    Wu, Mei-fang
    Deng, Yun
    Huang, Wen-qun
    Guo, Qiang
    Yang, Cheng-de
    Gu, Yue-ying
    Bao, Chun-de
    Chen, Shun-le
    CLINICAL RHEUMATOLOGY, 2007, 26 (10) : 1647 - 1654
  • [38] Thrombotic microangiopathy in an adult patient with clinically amyopathic dermatomyositis complicated with interstitial lung disease
    Sugimoto, T.
    Hajiro, T.
    Fujimoto, T.
    Kojyo, N.
    Horie, M.
    Kashiwagi, A.
    LUPUS, 2007, 16 (12) : 1004 - 1005
  • [39] Rapidly progressive interstitial lung fibrosis in a patient with amyopathic dermatomyositis and anti-MDA5 antibodies
    Gorka, Jacek
    Szczeklik, Wojciech
    Wludarczyk, Anna
    Loboda, Piotr
    Chmura, Lukasz
    Musial, Jacek
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2015, 125 (09): : 685 - 686
  • [40] Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis
    Ho So
    Victor Tak Lung Wong
    Virginia Weng Nga Lao
    Hin Ting Pang
    Ronald Man Lung Yip
    Clinical Rheumatology, 2018, 37 : 1983 - 1989
12345